Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk.

[1]  A. Struthers,et al.  Allopurinol Improves Endothelial Dysfunction in Chronic Heart Failure , 2002, Circulation.

[2]  Rainer Hambrecht,et al.  Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart Failure: Results From 2 Placebo-Controlled Studies , 2002, Circulation.

[3]  T. Panetta,et al.  Identification of uric acid and xanthine oxidase in atherosclerotic plaque. , 2001, The American journal of cardiology.

[4]  F Santeusanio,et al.  Relation Between Serum Uric Acid and Risk of Cardiovascular Disease in Essential Hypertension: The PIUMA Study , 2000, Hypertension.

[5]  D. Harrison,et al.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.

[6]  Xiaoping Liu,et al.  Regulation of Xanthine Oxidase by Nitric Oxide and Peroxynitrite* , 2000, The Journal of Biological Chemistry.

[7]  A. Morris,et al.  Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. , 2000, Hypertension.

[8]  D. Green,et al.  NITRIC OXIDE‐DEPENDENT ENDOTHELIAL FUNCTION IS UNAFFECTED BY ALLOPURINOL IN HYPERCHOLESTEROLAEMIC SUBJECTS , 1999, Clinical and experimental pharmacology & physiology.

[9]  Daniel Levy,et al.  Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study , 1999, Annals of Internal Medicine.

[10]  G. Mancia,et al.  Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. , 1998, Atherosclerosis.

[11]  Ian Graham,et al.  Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. , 1998, European heart journal.

[12]  A. Quyyumi,et al.  Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. , 1997, Hypertension.

[13]  J. Kirwin,et al.  Identification of Uric Acid in AorticAneurysms and Atherosclerotic Artery , 1996, Annals of the New York Academy of Sciences.

[14]  P. Poole‐Wilson,et al.  Prevention of coronary heart disease in clinical practice , 1994 .